GILD · Gilead Sciences, Inc.
$129.35
-1.51 (-1.15%)
At close · Jul 24
Market Cap
$160.55B
Shares
1.24B
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-06-30 | — | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-05-20 | 2026-05-14 | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| 8-K | 2026-05-04 | 2026-04-30 | |
| 8-K | 2026-04-28 | — | |
| Investor Event Transcript | 2026-03-31 | — | |
| Investor Event Transcript | 2026-03-31 | — | |
| Investor Event Transcript | 2026-03-31 | — | |
| DEF 14A | 2026-03-20 | 2026-04-30 | |
| 10-K | 2026-02-24 | 2025-12-31 | |
| 8-K | 2026-02-23 | 2026-02-22 | |
| 8-K | 2026-02-10 | — | |
| Investor Event Transcript | 2025-12-31 | — | |
| 8-K | 2025-11-19 | 2025-11-15 | |
| 10-Q | 2025-11-07 | 2025-09-30 | |
| 8-K | 2025-10-30 | — | |
| 8-K | 2025-10-06 | — | |
| 8-K | 2025-08-14 | 2025-08-10 | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-08-04 | 2025-07-30 | |
| 8-K | 2025-05-08 | 2025-05-07 | |
| 10-Q | 2025-05-07 | 2025-03-31 | |
| 8-K | 2025-04-24 | — | |
| DEF 14A | 2025-03-27 | 2025-05-07 | |
| 8-K | 2025-03-12 | 2025-03-09 | |
| 10-K | 2025-02-28 | 2024-12-31 | |
| 8-K | 2025-02-11 | — | |
| 8-K/A | 2024-12-13 | 2024-07-17 | |
| 8-K | 2024-11-20 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-11-06 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-08 | — | |
| 8-K | 2024-07-17 | — | |
| 8-K | 2024-05-09 | 2024-05-08 | |
| 10-Q | 2024-05-08 | 2024-03-31 | |
| 8-K | 2024-04-25 | — | |
| DEF 14A | 2024-03-28 | 2024-05-08 | |
| 8-K | 2024-03-22 | — | |
| 8-K | 2024-03-14 | 2024-03-10 | |
| 10-K | 2024-02-23 | 2023-12-31 | |
| 8-K | 2024-02-12 | 2024-02-11 | |
| 8-K | 2024-02-06 | — | |
| 8-K | 2024-02-02 | 2024-02-01 | |
| 8-K | 2023-11-07 | — | |
| 10-Q | 2023-11-07 | 2023-09-30 | |
| 8-K | 2023-09-14 | — |
Showing 1–50 of 107 filings
Key facts
CIK
882095
CUSIP
375558103
13F (30d)
731 filings
698 filers
Visit website
Investor relations